We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 2,068 results
  1. Neutralizing anti-diphtheria toxin scFv produced by phage display

    Background

    Diphtheria can be prevented by vaccination, but some epidemics occur in several places, and diphtheria’s threat is considerable....

    Ehsan Khalili, Mostafa Lakzaei, Mahdi Aminian in Biotechnology Letters
    Article 12 April 2024
  2. Therapeutic potential of a novel IP-10-(anti-HER2 scFv) fusion protein for the treatment of HER2-positive breast cancer

    Objectives

    Interferon-γ-inducible protein 10 (IP-10) is a potent antitumor agent and acts by its angiostatic and immunomodulatory properties. IP-10...

    Maryam Ahmadzadeh, Elham Mohit in Biotechnology Letters
    Article 18 January 2023
  3. Bacterial production and biophysical characterization of a hard-to-fold scFv against myeloid leukemia cell surface marker, IL-1RAP

    Background

    Interleukin-1 receptor accessory protein (IL-1RAP) is one of the most promising therapeutic targets proposed for myeloid leukemia....

    Aref Farokhi-Fard, Elham Bayat, ... Fatemeh Davami in Molecular Biology Reports
    Article 26 November 2022
  4. Construction of Human Immune and Naive scFv Phage Display Libraries

    Antibody phage display is a widely used in vitro selection technology for the generation of human recombinant antibodies and has yielded thousands of...
    Maximilian Ruschig, Philip Alexander Heine, ... Michael Hust in Phage Display
    Protocol 2023
  5. Combining of synthetic VHH and immune scFv libraries for pregnancy-associated glycoproteins ELISA development

    Abstract

    Nanobodies (VHH) from camelid antibody libraries hold great promise as therapeutic agents and components of immunoassay systems. Synthetic...

    Dmitri Dormeshkin, Michail Shapira, ... Andrei Gilep in Applied Microbiology and Biotechnology
    Article 20 June 2022
  6. Design and construction of scFv-PE35KDEL as a novel immunotoxin against human epidermal growth factor receptor 2 for cancer therapy

    Propose

    Human epidermal growth factor receptor 2 (HER2) is overexpressed on the surface of some kinds of cancer cells including breast cancer. In this...

    Zahra Shariaty Vaziri, Fatemeh Shafiee, Vajihe Akbari in Biotechnology Letters
    Article 20 February 2023
  7. Designing a Humanized Immunotoxin Based on HER2 Specific scFv and DFF40 Toxin Against Breast Cancer: An In-Silico Study

    Breast cancer is the most frequent cancer in women worldwide. Human epidermal growth factor receptor 2 (HER2) is a receptor which is overexpressed in...

    Ahmad Movahedpour, Khadijeh Ahmadi, ... Navid Nezafat in International Journal of Peptide Research and Therapeutics
    Article 21 July 2022
  8. Tuning the ignition of CAR: optimizing the affinity of scFv to improve CAR-T therapy

    How single-chain variable fragments (scFvs) affect the functions of chimeric antigen receptors (CARs) has not been well studied. Here, the components...

    Yanting Duan, Ruoqi Chen, ... Jie Sun in Cellular and Molecular Life Sciences
    Article 29 December 2021
  9. Specific anti-SARS-CoV-2 S1 IgY-scFv is a promising tool for recognition of the virus

    As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread globally, a series of vaccines, antibodies and drugs have been...

    Shikun Ge, Rao Wu, ... **aoying Zhang in AMB Express
    Article Open access 12 February 2022
  10. Facile One-Step Generation of Camelid VHH and Avian scFv Libraries for Phage Display by Golden Gate Cloning

    Since its development in the 1980s, the Nobel Prize-awarded phage display technology has been one of the most commonly used in vitro selection...
    Christina Bauer, Elke Ciesielski, ... Carolin Sellmann in Genotype Phenotype Coupling
    Protocol 2023
  11. Optimization of Tris/EDTA/Sucrose (TES) periplasmic extraction for the recovery of functional scFv antibodies

    Single-chain variable fragments (scFvs) have gained increased attention among researchers in both academic and industrial fields owing to simple...

    Elham Ghamghami, Marjan Abri Aghdam, ... Behzad Baradaran in AMB Express
    Article Open access 20 July 2020
  12. Single-chain variable fragment-based immunoassay for bioactive natural products

    Bioactive natural products (BNPs) from medicinal plants are one of the most successful sources for new drugs. As BNPs contain the beneficial and...

    **** Cui, Jian Lu, ... Peng Li in Phytochemistry Reviews
    Article 29 April 2023
  13. Production and applications of fluorobody from redox-engineered Escherichia coli

    Abstract

    Efficient selection and production of antibody fragments in microbial systems remain to be a challenging process. To optimize microbial...

    Witsanu Srila, Thae Thae Min, ... Montarop Yamabhai in Applied Microbiology and Biotechnology
    Article Open access 02 February 2023
  14. Cloning, Expression and One-Step Purification of a Novel IP-10-(anti-HER2 scFv) Fusion Protein in Escherichia coli

    Breast cancer is the most common cancer in women, worldwide. The correlation between breast cancer malignancy and human epidermal growth factor 2...

    Maryam Ahmadzadeh, Farzaneh Farshdari, ... Elham Mohit in International Journal of Peptide Research and Therapeutics
    Article 20 July 2020
  15. Inhibition of beet necrotic yellow vein virus by the expression of a single-chain variable fragment antibody in sugar beet plants

    Rhizomania caused by the Beet necrotic yellow vain virus (BNYVV) is the most damaging disease of sugar beet worldwide. Antibody-based resistance was...

    Mahboobe Jafarzade Bajestani, Mohammad Ali Malboobi, ... Maryam Khoshnami in European Journal of Plant Pathology
    Article 18 October 2022
  16. Antibody and antibody fragments site-specific conjugation using new Q-tag substrate of bacterial transglutaminase

    During the last few years Antibody-Drug Conjugates (ADCs) have become one of the most active and very promising therapeutic weapons. Lessons learned...

    Meddy El Alaoui, Eva Sivado, ... Said El Alaoui in Cell Death Discovery
    Article Open access 15 February 2024
  17. Antibody Batch Cloning

    The antigen-binding ability of each antibody clone selected by phage display is usually initially ranked by a screening ELISA using monovalent scFv...
    Rico Ballmann, Kai-Thomas Schneider, ... Stefan Dübel in Phage Display
    Protocol 2023
  18. Extracellular domains of CARs reprogramme T cell metabolism without antigen stimulation

    Metabolism is an indispensable part of T cell proliferation, activation and exhaustion, yet the metabolism of chimeric antigen receptor (CAR)-T cells...

    Aliya Lakhani, **min Chen, ... Junyoung O. Park in Nature Metabolism
    Article 24 April 2024
  19. Genome-scale metabolic model-based engineering of Escherichia coli enhances recombinant single-chain antibody fragment production

    Purpose

    Escherichia coli is an attractive and cost-effective cell factory for producing recombinant proteins such as single-chain variable fragments...

    Aidin Behravan, Atieh Hashemi, ... Hamideh Fouladiha in Biotechnology Letters
    Article 08 September 2022
  20. A Novel Specific Single-Chain Variable Fragment Diagnostic System for Viral Hemorrhagic Septicemia Virus

    Viral hemorrhagic septicemia virus (VHSV), one of the most important viral marine pathogens worldwide, has a broad range of hosts, such as members of...

    Haneul Seo, Andre Ditya Maulana Lubis, Sukchan Lee in Marine Biotechnology
    Article 08 September 2022
Did you find what you were looking for? Share feedback.